Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | DNM1 | Q05193 | 5/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.32 |
| ▸ | GABBR2 | O75899 | 1/20 | 0.32 |
| ▸ | GABBR1 | Q9UBS5 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19206137 | 0.87 | — | — | |
| SCHEMBL7718395 | 0.87 | — | — | |
| SCHEMBL6516983 | 0.87 | — | — | |
| SCHEMBL11137 | 0.87 | — | — | |
| Trimethylammonium SCHEMBL27533199 | 0.85 | LMNA (0.44) | LMNAALDH1A1HIF1AHTTGABRR1 | |
| SCHEMBL689269 | 0.85 | — | — | |
| SCHEMBL14888870 | 0.85 | — | — | |
| Water SCHEMBL20657269 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL9053484 | 0.85 | — | — | |
| SCHEMBL16694320 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10888510-B2 | Process for dyeing keratin fibres using at least one particular 2- or 4-azopyridinium dye and at least one fluorescent dye | L'OREAL (FR) | 2021-01-12 | — | — | US | disclosed |
| US-20190343750-A1 | PROCESS FOR DYEING KERATIN FIBRES USING AT LEAST ONE PARTICULAR 2- OR 4-AZOPYRIDINIUM DYE AND AT LEAST ONE FLUORESCENT DYE | L'OREAL (FR) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10888510-B2 | Process for dyeing keratin fibres using at least one particular 2- or 4-azopyridinium dye and at least one fluorescent dye | KRT18, IK, GLA | LMNA 521/4885ALDH1A1 300/4885DNM1 4579/4885 |
| US-20190343750-A1 | PROCESS FOR DYEING KERATIN FIBRES USING AT LEAST ONE PARTICULAR 2- OR 4-AZOPYRIDINIUM DYE AND AT LEAST ONE FLUORESCENT DYE | KRT18, IK, GLA | LMNA 521/4885ALDH1A1 300/4885DNM1 4579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.